My Profile Shopping Cart Register Login
Logo and Name
 
CME/CE Programs About Us Why Register? Advisory Panel Links Contact Home
 
 

Printer-Friendly

Email Page


Take Test
Start the program by clicking on the Start Program icon at the bottom of this page.

Program Title
The Ongoing Evolution of Brain Tumor Response Criteria

Release Date: December-08-09
Credit Expiration Date: December-08-10
Program Developer/Facilitator

Medical Communications Media, Inc.
Target Audience
This educational activity is designed to meet the needs of neurosurgeons, neuro-oncologists, radiation oncologists, medical oncologists, and other healthcare providers interested in the treatment of primary gliomas.
Credit Hours
CME 0.25
Medium
e-Monograph
Program Description
Response criteria for assessment of glioma were first introduced in 1977. While revisions followed to address some of the original criteria's shortcomings, response criteria measures continue to evolve, and proposed modifications continue to fine-tune quantifiable measures to assist in the care of patients with glioma.
Learning Objectives
Upon completion of this educational activity, the participant should be able to:
1.
 Compare the previous response criteria with the proposed RANO criteria for high-grade glioma.
Faculty
Marc C. Chamberlain, MD
Professor of Neurology
Department of Neurology and Neurosurgery
University of Washington / Fred Hutchinson Cancer Center
Seattle, Washington, USA


Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.


Dr. Chamberlain discloses product consultation and speakers’ bureau participation for Schering-Plough and Genentech.
Commercial Support Statements
This activity is supported by an educational grant from Schering-Plough Corporation.
Credit Statements
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AKH Inc. and Medical Communications Media, Incorporated. AKH Inc. is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc. designates this educational activity for a maximum of 0.25 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Instructions
1.
 Please turn off all pop-up blockers and click on the "Start Program" icon at the bottom of the page. If you have not previously registered with this website, you will be taken to the login/registration page where you will be able to register as a new GliomaEd.com member. If you have previously registered, you will be asked to verify or correct existing registration information. When ready, click on the "Start Program" icon.
2.
 This program, post-test, and evaluation will take approximately 15 minutes to complete.
3.
 Instructions for completing and submitting the post-test are provided on the post-test screen. A minimum score of 100% on the post-test is required for a CME certificate. One retake is permitted.
Certificate Fee

$0.00

Disclaimer
© 2009. All rights reserved. None of the contents of this publication may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this publication are those of the faculty members and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, AKH Inc., or Schering-Plough. Any medications, diagnostic procedures, or treatments discussed by the faculty members should not be used by clinicians or other healthcare professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

Printer-Friendly

Email Page

Start Program

Take Test
By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.